171 related articles for article (PubMed ID: 21283654)
1. Recent advances in magnetic resonance imaging of prostate cancer.
Lawrentschuk N; Lindner U
F1000 Med Rep; 2010 Dec; 2():86. PubMed ID: 21283654
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.
Fujihara A; Iwata T; Shakir A; Tafuri A; Cacciamani GE; Gill K; Ashrafi A; Ukimura O; Desai M; Duddalwar V; Stern MS; Aron M; Palmer SL; Gill IS; Abreu AL
BJU Int; 2021 Jun; 127(6):712-721. PubMed ID: 33043575
[TBL] [Abstract][Full Text] [Related]
3. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
4. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided biopsies and minimally invasive therapy for prostate cancer.
Ghai S; Trachtenberg J
Indian J Urol; 2015; 31(3):209-16. PubMed ID: 26166964
[TBL] [Abstract][Full Text] [Related]
6. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
[TBL] [Abstract][Full Text] [Related]
7. Comparison of double inversion recovery magnetic resonance imaging (DIR-MRI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in detection of prostate cancer: A pilot study.
Onwuharine EN; Clark AJ
Radiography (Lond); 2020 Aug; 26(3):234-239. PubMed ID: 32052752
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
9. An update on prostate biopsy in the era of magnetic resonance imaging.
Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
[TBL] [Abstract][Full Text] [Related]
10. Imaging in prostate cancer diagnosis: present role and future perspectives.
Pinto F; Totaro A; Calarco A; Sacco E; Volpe A; Racioppi M; D'Addessi A; Gulino G; Bassi P
Urol Int; 2011; 86(4):373-82. PubMed ID: 21372554
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
Durmus T; Baur A; Hamm B
Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
[TBL] [Abstract][Full Text] [Related]
14. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
15. Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.
Barret E; Turkbey B; Puech P; Durand M; Panebianco V; Fütterer JJ; Renard-Penna R; Rouvière O
World J Urol; 2019 Mar; 37(3):429-436. PubMed ID: 30003373
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Woo S; Suh CH; Eastham JA; Zelefsky MJ; Morris MJ; Abida W; Scher HI; Sidlow R; Becker AS; Wibmer AG; Hricak H; Vargas HA
Eur Urol Oncol; 2019 Nov; 2(6):605-616. PubMed ID: 31204311
[TBL] [Abstract][Full Text] [Related]
17. Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer.
Leapman MS; Wang R; Park HS; Yu JB; Weinreb JC; Gross CP; Ma X
Urology; 2019 Feb; 124():98-106. PubMed ID: 30107188
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric (mp) MRI of prostate cancer.
Kumar V; Bora GS; Kumar R; Jagannathan NR
Prog Nucl Magn Reson Spectrosc; 2018 Apr; 105():23-40. PubMed ID: 29548365
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
Osses DF; Drost FH; Verbeek JFM; Luiting HB; van Leenders GJLH; Bangma CH; Krestin GP; Roobol MJ; Schoots IG
BJU Int; 2020 Jul; 126(1):124-132. PubMed ID: 32232921
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
